Revive Therapeutics Ltd. (RVV.CX)
0.025
0.00 (0.00%)
CAD |
CNSX |
Aug 25, 10:30
Revive Therapeutics Price to Book Value
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 27, 2025 | 1.408 |
| June 26, 2025 | 1.408 |
| June 25, 2025 | 1.408 |
| June 24, 2025 | 1.408 |
| June 23, 2025 | 1.408 |
| June 20, 2025 | 1.761 |
| June 19, 2025 | 1.408 |
| June 18, 2025 | 1.408 |
| June 17, 2025 | 1.408 |
| June 16, 2025 | 1.761 |
| June 13, 2025 | 1.761 |
| June 12, 2025 | 1.408 |
| June 11, 2025 | 1.761 |
| June 10, 2025 | 2.113 |
| June 09, 2025 | 2.465 |
| June 06, 2025 | 2.113 |
| June 05, 2025 | 1.761 |
| June 04, 2025 | 2.113 |
| June 03, 2025 | 2.113 |
| June 02, 2025 | 2.113 |
| May 30, 2025 | 2.113 |
| May 29, 2025 | 1.761 |
| May 28, 2025 | 1.761 |
| May 27, 2025 | 2.113 |
| May 26, 2025 | 1.761 |
| Date | Value |
|---|---|
| May 23, 2025 | 2.113 |
| May 22, 2025 | 1.761 |
| May 21, 2025 | 1.761 |
| May 20, 2025 | 1.761 |
| May 16, 2025 | 1.761 |
| May 15, 2025 | 1.761 |
| May 14, 2025 | 1.761 |
| May 13, 2025 | 1.761 |
| May 12, 2025 | 2.113 |
| May 09, 2025 | 2.113 |
| May 08, 2025 | 1.761 |
| May 07, 2025 | 2.113 |
| May 06, 2025 | 2.113 |
| May 05, 2025 | 1.761 |
| May 02, 2025 | 1.761 |
| May 01, 2025 | 2.113 |
| April 30, 2025 | 2.113 |
| April 29, 2025 | 2.113 |
| April 28, 2025 | 2.113 |
| April 25, 2025 | 1.761 |
| April 24, 2025 | 2.113 |
| April 23, 2025 | 2.113 |
| April 22, 2025 | 2.113 |
| April 21, 2025 | 2.113 |
| April 17, 2025 | 2.113 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| HLS Therapeutics, Inc. | 1.504 |
| Bausch Health Cos., Inc. | -- |
| Cipher Pharmaceuticals, Inc. | 1.848 |
| BioSyent, Inc. | 3.894 |
| Knight Therapeutics, Inc. | 1.216 |
Price to Book Value Related Metrics
| PEG Ratio | -0.006 |
| Price | 0.025 |
| Earnings Yield | -101.6% |
| Market Cap | 10.89M |
| PEGY Ratio | -0.006 |